104 4, which mandates up to 58% reduction on the retail prices of 87 high-cost medicines for top chronic diseases such as diabetes, hypertension, chronic kidney disease, asthma/chronic obstructive pulmonary disease, and cancer, took effect in June 2020. Generic and brand medicines and drugs.
Twenty percent (20%) discount and VAT exemption on the purchase of the following:
